Average Co-Inventor Count = 5.53
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alnylam Pharmaceuticals, Inc. (50 from 444 patents)
2. Arbutus Biopharma Corporation (3 from 57 patents)
3. Tekmira Pharmaceuticals Corporation (3 from 14 patents)
4. Massachusetts Institute of Technology (2 from 8,373 patents)
5. Eth Zurich (2 from 284 patents)
6. Vir Biotechnology, Inc. (2 from 8 patents)
7. USA As Represented by Secretary of the Navy (1 from 16,080 patents)
8. Genzyme Corporation (1 from 789 patents)
9. Regulus Therapeutics Inc. (1 from 61 patents)
10. The University of British Columbia (932 patents)
60 patents:
1. 12391945 - Coronavirus IRNA compositions and methods of use thereof
2. 12364762 - Biodegradable lipids for the delivery of active agents
3. 12350338 - Biodegradable lipids for the delivery of active agents
4. 12343398 - Biodegradable lipids for the delivery of active agents
5. 12338439 - Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof
6. 12239709 - Biodegradable lipids for the delivery of active agents
7. 12241064 - REVERSIR™ compounds
8. 12221607 - Multi-targeted single entity conjugates
9. 11679158 - Biodegradable lipids for the delivery of active agents
10. 11633479 - Biodegradable lipids for the delivery of active agents
11. 11633480 - Biodegradable lipids for the delivery of active agents
12. 11612657 - Biodegradable lipids for the delivery of active agents
13. 11590229 - Biodegradable lipids for the delivery of active agents
14. 11420931 - Lipid containing formulations
15. 11400158 - Biodegradable lipids for the delivery of active agents